Cutaneous malakoplakia in a patient with acquired immunodeficiency syndrome (AIDS)

American Journal of Dermatopathology

Volumn 20, Issue 2, 1998, Pages 185-188

  Barnard, Maja ^a   Chalvardjian, Ara ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acquired immunodeficiency syndrome; AIDS; Malakoplakia

Indexed keywords

ANTIINFECTIVE AGENT; CLOXACILLIN; PENICILLIN G; SAQUINAVIR;

ABSCESS DRAINAGE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; AXILLA; CASE REPORT; DRUG INDICATION; EXCISION; HISTIOCYTE; HUMAN; HUMAN TISSUE; MALACOPLAKIA; MALE; PHAGOSOME; PRIORITY JOURNAL; SKIN ABSCESS; SKIN BIOPSY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOLOGICAL MARKERS; BIOPSY; ESCHERICHIA COLI; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALACOPLAKIA; MALE; SKIN; SKIN DISEASES;

EID: 0031970664     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199804000-00015     Document Type: Article

References (14)

1. McClure J. Malakoplakia. J Pathol 1983;140:275-330.
2. Lowitt MH, Kariniemi A, Niemi KM, Kao GF. Cutaneous malakoplakia: a report of two cases and review of the literature. J Am Acad Dermatol 1996;34:325-32.
3. Kwon KY, Colby TV. Rhodococcus equi pneumonia and pulmonary malakoplakia in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1994;118:744-8.
4. Davis D, Bigler L, Shimazu C, Omura E. Cutaneous malakoplakia. J Cutan Pathol 1997;24:93.
5. Lou TY, Teplitz C. Malakoplakia: pathogenesis and ultrastructural morphogenesis - a problem of altered macrophage (phagolysosomal) response. Hum Pathol 1974;5:191-207.
6. Abdou NI, NaPombejara C, Sagawa A, et al. Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonists in vitro and in vivo. N Engl J Med 1977;297:1413-9.
7. Zerlauth G, Maier E, Chehadeh H, Zimmerman K, Eibl MM, Mannhalter JW. Interaction with human immunodeficiency virus type I modulates innate effector functions of human monocytes. J Infect Dis 1995;172:1598-601.
8. Newman SL. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis 1995;171:320-7.
9. Biggs BA, Hewish M, Kent S, Hayes K, Crowe SM. HIV-infection of human macrophages impairs phagocytosis and killing of Toxo-plasma gondii. J Immunol 1995;154:6132-9.
10. Poli G, Bottazzi B, Acero R, et al. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis. Clin Exp Immunol 1985;62:136-42.
11. Eales LJ, Mostael O, Pinching AJ. Microbicidal activity of monocyte derived macrophages in AIDS and related disorders. Clin Exp Immunol 1987;67:227-35.
12. Cockerell CJ, Friedman-Kien AE. Cutaneous infections in patients with human immunodeficiency virus infection. Infect Dis Ther 1989;3:135-42.
13. Cockerell CJ. Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: clinical and histological aspects. J Am Acad Dermatol 1990;22(6 Pt 2):1260-9.
14. van der Voort PHJ, ten Velden JJAM, Wassenaar RP, Silberbusch J. Malakoplakia: two case reports and a comparison of treatment modalities based on a literature review. Arch Intern Med 1996;156:577-83.